Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Gaedigk

Showing results (41-50 of 206) with videos related to

Pageof 21
Sort By:
Pharmacotherapy|August 14, 2002
CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6Y W Francis Lam, Andrea Gaedigk, Larry Ereshefsky, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 14, 2017
Age-dependent Protein Abundance of Cytosolic Alcohol and Aldehyde Dehydrogenases in Human LiverDeepak Kumar Bhatt, Andrea Gaedigk, Robin E Pearce, et al.
Pharmacogenomics|July 12, 2018
CYP2D6 genotype analysis of a Thai population: platform comparisonMonpat Chamnanphon, Andrea Gaedigk, Natchaya Vanwong, et al.
Clinical and Translational Science|April 19, 2024
Response to "DPYD genotyping panels: Impact of population diversity"Andrea Gaedigk, Amy J Turner, Cyrine E Haidar, et al.
The Pharmacogenomics Journal|March 22, 2021
CYP2D6 genotype and reduced codeine analgesic effect in real-world clinical practiceDaniel Carranza-Leon, Alyson L Dickson, Andrea Gaedigk, et al.
Clinical Pharmacology and Therapeutics|June 6, 2021
Pharmacogene Variation Consortium: A Global Resource and Repository for Pharmacogene VariationAndrea Gaedigk, Scott T Casey, Michelle Whirl-Carrillo, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|January 31, 2008
Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defectsAraba A Adjei, Andrea Gaedigk, Stephen D Simon, et al.
Human Molecular Genetics|August 30, 2013
Common CYP2D6 polymorphisms affecting alternative splicing and transcription: long-range haplotypes with two regulatory variants modulate CYP2D6 activityDanxin Wang, Ming J Poi, Xiaochun Sun, et al.
Frontiers in Pharmacology|April 7, 2022
The Identification of Novel <i>CYP2D6</i> Variants in US Hmong: Results From Genome Sequencing and Clinical GenotypingYa Feng Wen, Andrea Gaedigk, Erin C Boone, et al.
Pharmacogenomics|December 19, 2009
CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype predictionAndrea Gaedigk, Uwe Fuhr, Charlene Johnson, et al.
Pageof 21

Showing results (41-50 of 206) with videos related to

Sort By:
Pageof 21
Pharmacotherapy|August 14, 2002
CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6Y W Francis Lam, Andrea Gaedigk, Larry Ereshefsky, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 14, 2017
Age-dependent Protein Abundance of Cytosolic Alcohol and Aldehyde Dehydrogenases in Human LiverDeepak Kumar Bhatt, Andrea Gaedigk, Robin E Pearce, et al.
Pharmacogenomics|July 12, 2018
CYP2D6 genotype analysis of a Thai population: platform comparisonMonpat Chamnanphon, Andrea Gaedigk, Natchaya Vanwong, et al.
Clinical and Translational Science|April 19, 2024
Response to "DPYD genotyping panels: Impact of population diversity"Andrea Gaedigk, Amy J Turner, Cyrine E Haidar, et al.
The Pharmacogenomics Journal|March 22, 2021
CYP2D6 genotype and reduced codeine analgesic effect in real-world clinical practiceDaniel Carranza-Leon, Alyson L Dickson, Andrea Gaedigk, et al.
Clinical Pharmacology and Therapeutics|June 6, 2021
Pharmacogene Variation Consortium: A Global Resource and Repository for Pharmacogene VariationAndrea Gaedigk, Scott T Casey, Michelle Whirl-Carrillo, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|January 31, 2008
Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defectsAraba A Adjei, Andrea Gaedigk, Stephen D Simon, et al.
Human Molecular Genetics|August 30, 2013
Common CYP2D6 polymorphisms affecting alternative splicing and transcription: long-range haplotypes with two regulatory variants modulate CYP2D6 activityDanxin Wang, Ming J Poi, Xiaochun Sun, et al.
Frontiers in Pharmacology|April 7, 2022
The Identification of Novel <i>CYP2D6</i> Variants in US Hmong: Results From Genome Sequencing and Clinical GenotypingYa Feng Wen, Andrea Gaedigk, Erin C Boone, et al.
Pharmacogenomics|December 19, 2009
CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype predictionAndrea Gaedigk, Uwe Fuhr, Charlene Johnson, et al.
Pageof 21